Shire Strikes Back at Hedge Fund Patent Challenge Win
Troutman Sanders was named in a Dec. 23 Bloomberg BNA article for the firm’s representation of Shire’s pharmaceutical division, which is appealing a successful challenge to its patent on bowel drug Gattex made by The Coalition for Affordable Drugs (CAD), a hedge fund.